liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Improving anti-drug antibody assay performance in Gyrolab for therapeutic recombinant antibody Infliximab
Linköping University, Department of Clinical and Experimental Medicine. Linköping University, Faculty of Health Sciences.
2014 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Monoclonal antibodies can be used as targeting therapies for several diseases. One major concern when using these therapies is anti-drug antibodies which may hamper the drugs efficiency. Gyrolab is an automated platform which can be used to develop bridging immunoassays where the anti-drug antibodies affinity towards the monoclonal antibody is utilized. Anti-drug antibody immunoassay development on Gyrolab is limited mainly by three factors which may inappropriately affect signal intensity levels. In this project different variants of bridging immunoassays based on drug Fab fragments have been developed for monoclonal antibody Infliximab, with the purpose to illustrate the effects of these three factors.

Findings indicate that an assay based completely on drug Fab fragments is more sensitive compared to an assay based on intact drug since less affected by unspecific interactions between drug reagents and complex formations. Surprisingly findings also indicate that an assay based completely on drug Fab fragments is affected by human anti-hinge antibodies which decrease assay sensitivity. The most optimal assay variant is based on the combination between intact capture drug and Fab fragment as detection. This variant is insensitive to false positive reactions caused by Rheumatoid factor and human anti-hinge antibodies, less prone to form unspecific interactions between drug reagents and complex formations in the presence of anti-drug antibodies. The optimal assay variant also demonstrates best drug tolerance in combination with acid dissociation.

Place, publisher, year, edition, pages
2014. , 61 p.
National Category
Bioengineering Equipment
Identifiers
URN: urn:nbn:se:liu:diva-111527ISRN: LiU-IKE-EX—14/05--SEOAI: oai:DiVA.org:liu-111527DiVA: diva2:757338
Subject / course
Biotechnology
Presentation
2014-06-02, Hagdahlsalen, Campus US, Linköping, 14:00 (Swedish)
Supervisors
Examiners
Available from: 2014-10-22 Created: 2014-10-21 Last updated: 2014-10-22Bibliographically approved

Open Access in DiVA

Master thesis Cecilia Bill(2231 kB)600 downloads
File information
File name FULLTEXT01.pdfFile size 2231 kBChecksum SHA-512
0be479f7b57393e88c99a5bad26f82521e9fe284d47ffe0f9b15bbc79ff9427e6fa8628f47d3eb9e1bc77ad7702ede8eaa15c9d626b87ed10e0c2adef0562f64
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Cecilia, Bill
By organisation
Department of Clinical and Experimental MedicineFaculty of Health Sciences
Bioengineering Equipment

Search outside of DiVA

GoogleGoogle Scholar
Total: 600 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 835 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf